ガン治療のためのPHGDH阻害の活用:メカニズム,SAR,計算上の側面,および臨床的可能性
Md Mustahidul Islam1, Shivani Kasana1, Sakshi Priya1
1Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
Archiv der Pharmazie
|August 22, 2025
まとめ
3 リン酸脱水酵素 (PHGDH) は癌の成長に不可欠です. 薬剤によるPHGDH抑制と遺伝子静止は有望ですが,がん細胞は適応し,効果的な治療のために組み合わせ治療が必要になります.
科学分野:
- 生物化学
- 腫瘍学
- 薬物の発見
背景:
- 3 フォスフォグリセラート脱水素酵素 (PHGDH) は,セリン生物合成における重要な酵素である.
- 過剰発現したPHGDHは 成長や転移を促し 乳がん,メラノーマ,膠原腫などの 侵襲的ながんに抵抗力を与えます
- PHGDHをターゲットにすることは 癌治療の有望な治療戦略です
研究 の 目的:
- 癌におけるPHGDHの役割を検討する.
- PHGDH阻害剤とその治療的可能性について議論します.
- PHGDH阻害に対する抵抗を克服するための戦略を探求する.
主な方法:
- PHGDHに関する既存の文献のレビュー
- 小分子および共性PHGDH阻害剤の分析
- 遺伝子サイレンシング技術 (RNAi,CRISPR/Cas9) の検討
- 薬剤設計における計算方法とSAR分析の探索
主要な成果:
- PHGDH阻害剤 (例えば,NCT-503,CBR-5884,Withangulatin A) は,セリンを制限し,アポトーシスを誘導することによって強力な抗癌作用を示しています.
- 遺伝子静止はPHGDHを 治療目標として確認した
- 計算方法により,選択的なPHGDH阻害剤の発見が加速される.
結論:
- PHGDHは腫瘍学における有効な治療目標である.
- 癌細胞の適応と抵抗を克服するために 組み合わせ治療は不可欠です
- 進行中の研究は,精密腫瘍学のためのPHGDH阻害剤の最適化に焦点を当てています.
さらに関連する動画
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
28.4K
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.1K
関連する概念動画
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K